Contrasting Bruker Corporation (BRKR) & Its Competitors
Bruker Corporation (NASDAQ: BRKR) is one of 82 public companies in the “Advanced Medical Equipment & Technology” industry, but how does it weigh in compared to its competitors? We will compare Bruker Corporation to related companies based on the strength of its earnings, profitability, institutional ownership, analyst recommendations, valuation, risk and dividends.
Earnings and Valuation
This table compares Bruker Corporation and its competitors gross revenue, earnings per share and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|Bruker Corporation||$1.66 billion||$275.00 million||30.61|
|Bruker Corporation Competitors||$2.02 billion||$430.74 million||-71.64|
Bruker Corporation’s competitors have higher revenue and earnings than Bruker Corporation. Bruker Corporation is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
This is a summary of recent ratings for Bruker Corporation and its competitors, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Bruker Corporation Competitors||253||1813||3249||105||2.59|
Bruker Corporation presently has a consensus price target of $26.00, suggesting a potential downside of 15.06%. As a group, “Advanced Medical Equipment & Technology” companies have a potential downside of 6.75%. Given Bruker Corporation’s competitors stronger consensus rating and higher probable upside, analysts plainly believe Bruker Corporation has less favorable growth aspects than its competitors.
This table compares Bruker Corporation and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Bruker Corporation Competitors||-327.91%||-35.29%||-12.43%|
Risk & Volatility
Bruker Corporation has a beta of 1.09, suggesting that its share price is 9% more volatile than the S&P 500. Comparatively, Bruker Corporation’s competitors have a beta of 0.89, suggesting that their average share price is 11% less volatile than the S&P 500.
Institutional and Insider Ownership
65.4% of Bruker Corporation shares are held by institutional investors. Comparatively, 53.0% of shares of all “Advanced Medical Equipment & Technology” companies are held by institutional investors. 35.2% of Bruker Corporation shares are held by insiders. Comparatively, 17.2% of shares of all “Advanced Medical Equipment & Technology” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Bruker Corporation pays an annual dividend of $0.16 per share and has a dividend yield of 0.5%. Bruker Corporation pays out 16.0% of its earnings in the form of a dividend. As a group, “Advanced Medical Equipment & Technology” companies pay a dividend yield of 0.9% and pay out 26.3% of their earnings in the form of a dividend.
Bruker Corporation beats its competitors on 8 of the 15 factors compared.
Bruker Corporation Company Profile
Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment. The Bruker BioSpin Group segment designs, manufactures and distributes enabling life science tools. The Bruker CALID segment designs, manufactures and distributes life science mass spectrometry instruments that can be integrated and used along with other sample preparation or chromatography instruments, as well as chemical, biological, radiological, nuclear and explosive detection products. The Bruker Nano segment designs, manufactures and distributes spectroscopy and microscopy instruments. The BEST segment develops and manufactures superconducting and non-superconducting materials and devices. It also focuses on nanomechanical testing instruments.
Receive News & Ratings for Bruker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.